论文信息 - Tumor-Speci ﬁ c Major Histocompatibility-II Expression Predicts Bene ﬁ t to Anti – PD-1/L1 Therapy in Patients With HER2-Negative Primary Breast Cancer - 字舞流文

Tumor-Speci ﬁ c Major Histocompatibility-II Expression Predicts Bene ﬁ t to Anti – PD-1/L1 Therapy in Patients With HER2-Negative Primary Breast Cancer

L. Pusztai | H. Gómez | P. Gonzalez-Ericsson | J. Balko | K. Blenman | Q. Sheng | R. Gallagher | V. Sanchez | M. Axelrod | M. Sanders | Na Luo | E. Petricoin | Julia D. Wulfkhule | Xiaopeng Sun | P. González-Ericsson | Paula I. González-Ericsson | Rosa I. Gallagher | Paula I. Gonzalez-Ericsson